89bio, Inc. (NASDAQ:ETNB – Get Rating) CEO Rohan Palekar sold 15,000 shares of the stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $20.00, for a total transaction of $300,000.00. Following the sale, the chief executive officer now owns 286,978 shares in the company, valued at approximately […]
Shares of 89bio, Inc. (NASDAQ:ETNB – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $17.87, but opened at $17.00. 89bio shares last traded at $17.21, with a volume of 250,812 shares changing hands. Analyst Upgrades and Downgrades A number of equities research analysts have issued reports […]
Shares of 89bio, Inc. (NASDAQ:ETNB – Get Rating) reached a new 52-week high on Tuesday after HC Wainwright raised their price target on the stock from $30.00 to $35.00. The company traded as high as $18.18 and last traded at $18.17, with a volume of 844414 shares changing hands. The stock had previously closed at […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) saw a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 7,640,000 shares, a decrease of 5.1% from the March 31st total of 8,050,000 shares. Based on an average daily volume of 2,180,000 shares, the short-interest ratio is presently […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 7,640,000 shares, a drop of 5.1% from the March 31st total of 8,050,000 shares. Based on an average daily trading volume, of 2,180,000 shares, the days-to-cover ratio is […]